CTRI/2023/05/052602已完成Unknown
An open label, randomized, two treatments, two sequences, two periods, single dose, crossover, bioequivalence study of Liposomal Amphotericin B powder for solution for Infusion, 50 mg/vial of Bharat Serums and Vaccines Ltd, India and AmBisome® 50mg/vial marketed by Gilead in healthy volunteers
Bharat Serums and Vaccines Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Healthy male volunteers
- •Subject who can give written informed consent and communicate effectively
排除标准
- •History of any major surgical procedure
- •History of any clinically significant medical conditions.
- •History of chronic alcoholism/ chronic smoking/ drug of abuse.
- •Subjects with known hypersensitivity to Liposomal Amphotericin B or any of the excipients.
研究者
相似试验
尚未招募
不适用
Comparative oral bioequivalence study of DICOMEX (Clozapine) 100 mg tablet ofLaboratorios Recalcine S.A., Chile and Clozaril® (Clozapine) 100 mg tablet of NovartisPharmaceutical CorporatioCTRI/2015/10/006303aboratorios Recalcine SA36
已完成
不适用
A study to monitor the safety and to assess thesteady-state bioequivalence of Imatinib Mesylate 400 mg tablets of SunPharmaceutical Industries Ltd, India in Chronic Myeloid Leukemia (CML) patientsCTRI/2014/03/004484Sun Pharmaceutical Industries Ltd36
已完成
1 期
A Phase I Clinical study to evaluate PK & PD of GeneSys Insulin Glargine.CTRI/2020/09/027956GeneSys Biologics Pvt Ltd
已完成
1 期
Study on 100 IU/mL Insulin Glargine injectioCTRI/2020/05/025383Virchow Biotech Private Limited24
尚未招募
不适用
Bioequivalence study of Gabapentin 300mg capsule of Alborzdarou Pharm Co.,euralgia and neuropathic disorders.IRCT20190706044111N6Alborzdarou Pharm. Co.24